| PDF (891kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-268258
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.26825
Zusammenfassung
In two groups of volunteers pharmacological parameters of the antihypotensive drug midodrine have been investigated. The first group of 12 male healthy volunteers received 2.5 mg midodrine hydrochloride intravenously, as drinking solution or as tablet according to a randomized cross-over design. Plasma and urine samples were analyzed for midodrine and its main metabolite ST 1059 by ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags